期刊文献+

抗C1_q抗体与系统性红斑狼疮疾病活动及狼疮肾炎的关系 被引量:4

Relationship of Anti-C1_q Autoantibodies to Disease Activity and Lupus Nephritis in Systemic Lupus Erythematosus
原文传递
导出
摘要 目的探讨血清抗C1q抗体(C1qAb)与系统性红斑狼疮(SLE)疾病活动、狼疮肾炎(LN)的关系。方法应用酶联免疫吸附试验(ELISA)检测60例SLE患者(A组),40例非SLE的自身免疫性疾病患者(B组),40例非LN肾脏疾病患者(C组),30例健康对照者(D组)的血清C1qAb水平。结果①A组患者血清C1qAb水平显著高于C组患者(P<0.05),C组患者血清C1qAb水平显著高于B组(P<0.05),B组患者血清C1qAb水平显著高于D组(P<0.05)。②活动期SLE患者血清C1qAb水平显著高于稳定期SLE患者(P<0.05)。③LN患者血清C1qAb水平显著高于非LN的SLE患者(P<0.05)。结论血清C1qAb水平可作为判断SLE患者病情活动情况、并发LN与否的重要指标。 Objective To investigate the relationship of serum anti-C1 q autoantibodies (ClqAb) to disease activity and Lu- pus nephritis (LN) in Systemic lupus erythematosus (SLE). Methods The serum C1 qAb of 60 cases of SLE (Group A) ,40 ca- ses of non-SLE patients with autoimmune diseases( Group B) ,40 cases of non-LN patients with renal diseases( Group C) ,30 ca- ses of healthy controls ( Group D ) was measured by Enzyme-linked immnnosorbent assay (ELISA). Results (~The serum C1 qAb in Group A was significantly higher than that in Group C ( P 〈 O. 05 ), which was significantly higher than that in Group B ( P 〈 0.05 ), and the serum C lqAb in Group B was significantly higher than that in Group D (P 〈 0.05 ). (~)The serum C1 qAh in pa- tients with active SLE was significantly higher than that in patients with stable SLE(P 〈0.05 ). (~)The serum ClqAb in patients with LN was significantly higher than that in non-LN patients with SLE ( P 〈 0.05 ). Conclusion The serum ClqAb provided an indicator that can be used to judge the disease activity and complication with LN in SLE.
出处 《中华全科医学》 2013年第7期1039-1040,共2页 Chinese Journal of General Practice
关键词 抗C1Q抗体 系统性红斑狼疮 狼疮肾炎 酶联免疫吸附试验 Anti-Clq autoantibodies Systemic lupus erythematosus Lupus nephritis Enzyme-linked immunosorhent assay
  • 相关文献

参考文献10

二级参考文献50

  • 1白艳艳,孙红胜,张源潮.狼疮肾炎39例临床分析[J].山东医药,2008,48(20):36-37. 被引量:2
  • 2李志军,陈琳洁,范晓云,李茂胜.系统性红斑狼疮并发细菌感染的危险因素分析[J].实用全科医学,2004,2(5):383-384. 被引量:4
  • 3崔太根,侯凡凡,倪兆慧,陈香美,张凤山,朱彤莹,赵学智,鲍春德,赵明辉,王国保,钱家麒,蔡广研,李英楠,陆福明,梅长林,邹万忠,王海燕.来氟米特联合糖皮质激素治疗增殖型狼疮性肾炎的多中心对照临床试验研究[J].中华内科杂志,2005,44(9):672-676. 被引量:104
  • 4Liu C C, Kao A H, Hawkins D M, et al. Lymphocyte bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus[J]. Clin Transl Sci, 2009,2 (4) :300-308.
  • 5Botto M, Walport M J. C1q, autoimmunity and apoptosis[J]. Immunobiology,2002,205(4-5) :395-406.
  • 6Dragon-Durey M A, Fremeaux-Bacchi V, Loirat C, et al. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or memhranoproliferative glomerulonephritis: report and genetic analysis of 16 cases[J]. J Am Soc Nephrol,2004,15(3) :787-795.
  • 7Hochberg M C. Updating the American College of Rheumatology revised criteria for the classification o{ systemic lupus erythematosus[J]. Arthritis Rheum, 1997,40(9):1725.
  • 8Yokoyama H, Wada T, Hara A, et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese[J]. Kidney Int,2004,66(6) :2382-2388.
  • 9DiScipio R G. Uhrastructures and interactions of complcmcnt factors H and I[J]. J Immunol,1992,1,19(8):2592-2599.
  • 10Leffler J, Herbert A P, NorstromE, et al. Annexin-II , DNA, and histones serve as factor H ligands on the surface of apoptotic cells[J]. J Biol Chem,2010,285(6):3766-3776.

共引文献580

同被引文献78

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部